Bridgewater Associates Portfolio holdings
Bridgewater Associates, founded in 1975 by Ray Dalio in New York and now headquartered in Westport, Connecticut, is the world’s largest hedge fund, managing over $125 billion in assets as of late 2024, serving institutional clients like pension funds, endowments, and sovereign wealth funds. Known for its pioneering "Pure Alpha" and "All Weather" strategies, the firm uses a systematic, macroeconomic approach to deliver uncorrelated returns and risk parity across global markets, including equities, bonds, currencies, and commodities, guided by rigorous data analysis and radical transparency. Dalio, who stepped down as co-CIO in 2022, built a unique culture of "radical truth" and "thoughtful disagreement," documented in his book *Principles*, though the firm transitioned leadership to co-CEOs Nir Bar Dea and Mark Bertolini in 2023 amid succession planning. With around 1,300 employees and a history of navigating crises like 2008 with gains, Bridgewater remains a titan in alternative investments, blending intellectual rigor with a distinctive, often polarizing management philosophy.
Top Buys
| 1 |
Eli Lilly
LLY
|
$149M |
| 2 |
NVIDIA
NVDA
|
$109M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
$96.2M |
| 4 |
Comcast
CMCSA
|
$72.7M |
| 5 |
Progressive
PGR
|
$70.4M |
Top Sells
| 1 |
Costco
COST
|
$92.8M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
$82.1M |
| 3 |
Coca-Cola
KO
|
$58.5M |
| 4 |
Broadcom
AVGO
|
$58.3M |
| 5 |
Lam Research
LRCX
|
$51M |
Sector Composition
| 1 | Consumer Staples | 23.84% |
| 2 | Healthcare | 20.59% |
| 3 | Consumer Discretionary | 12.23% |
| 4 | Financials | 6.67% |
| 5 | Communication Services | 5.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
701
Vertiv
VRT
$47.4B
| $514K | ﹤0.01% |
10,707
-50,268
| -82% | -$2.41M |
|
702
A.O. Smith
AOS
$10.3B
| $514K | ﹤0.01% |
6,233
-371
| -6% | -$30.6K |
|
703
Arista Networks
ANET
$180B
| $514K | ﹤0.01% |
8,724
-156,072
| -95% | -$9.19M |
|
704
Ultragenyx Pharmaceutical
RARE
$3.07B
| $509K | ﹤0.01% |
10,635
-754
| -7% | -$36.1K |
|
705
Home Depot
HD
$417B
| $507K | ﹤0.01% |
+1,464
| New | +$507K |
|
706
International Paper
IP
$25.7B
| $492K | ﹤0.01% |
13,615
+178
| +1% | +$6.44K |
|
707
NeoGenomics
NEO
$1.03B
| $483K | ﹤0.01% |
29,833
-118,513
| -80% | -$1.92M |
|
708
Bausch Health
BHC
$2.72B
| $445K | ﹤0.01% |
55,223
-34,939
| -39% | -$281K |
|
709
Principal Financial Group
PFG
$17.8B
| $444K | ﹤0.01% |
5,647
-15,983
| -74% | -$1.26M |
|
710
BioNTech
BNTX
$27B
| $431K | ﹤0.01% |
+4,083
| New | +$431K |
|
711
Korn Ferry
KFY
$3.83B
| $428K | ﹤0.01% |
7,219
-63,329
| -90% | -$3.76M |
|
712
Hanover Insurance
THG
$6.35B
| $428K | ﹤0.01% |
3,523
-10,976
| -76% | -$1.33M |
|
713
Treace Medical Concepts
TMCI
$453M
| $427K | ﹤0.01% |
33,520
-16,442
| -33% | -$210K |
|
|
HPP
714
Hudson Pacific Properties
HPP
$1.16B
| $427K | ﹤0.01% |
45,904
+2,399
| +6% | +$22.3K |
|
715
WEX
WEX
$5.87B
| $421K | ﹤0.01% |
+2,165
| New | +$421K |
|
|
CTLT
716
DELISTED
CATALENT, INC.
CTLT
| $419K | ﹤0.01% |
9,321
-227
| -2% | -$10.2K |
|
717
Morgan Stanley
MS
$236B
| $418K | ﹤0.01% |
4,483
+1,280
| +40% | +$119K |
|
718
Norfolk Southern
NSC
$62.3B
| $405K | ﹤0.01% |
1,712
-64,018
| -97% | -$15.1M |
|
719
Oracle
ORCL
$654B
| $404K | ﹤0.01% |
+3,834
| New | +$404K |
|
720
UDR
UDR
$13B
| $399K | ﹤0.01% |
10,410
+532
| +5% | +$20.4K |
|
721
T Rowe Price
TROW
$23.8B
| $385K | ﹤0.01% |
3,572
+347
| +11% | +$37.4K |
|
722
Fortinet
FTNT
$60.4B
| $374K | ﹤0.01% |
6,386
-147,302
| -96% | -$8.62M |
|
723
Alnylam Pharmaceuticals
ALNY
$59.2B
| $373K | ﹤0.01% |
1,951
+65
| +3% | +$12.4K |
|
724
Goldman Sachs
GS
$223B
| $329K | ﹤0.01% |
854
-579
| -40% | -$223K |
|
725
ConocoPhillips
COP
$116B
| $328K | ﹤0.01% |
2,828
-278
| -9% | -$32.3K |
|